Restenosis in coronary bare metal stents. Importance of time to follow-up: A comparison of coronary angiograms 6 months and 4 years after implantation

References

• Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, et al. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994; 331: 489–95
   PubMed Web of Science ®Google Scholar
• Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994; 331: 496–501
   PubMed Web of Science ®Google Scholar
• de Jaegere P, Mudra H, Figulla H, Almagor Y, Doucet S, Penn I, et al. IVUS guided optimised stent deployment: Immediate and 6 months clinical angiographic results from Multicenter Ultrasound Stenting in Coronaries study (MUSIC). Eur Heart J. 1998; 19: 1214–23
   PubMed Web of Science ®Google Scholar
• Lansky AJ, Roubin GS, O'Shaughnessy CD, Moore PB, Dean LS, Raizner AE, et al. Randomized comparison of GR-II stent and Palmaz-Schatz stent for elective treatment of coronary stenoses. Circulation. 2000; 102: 1364–8
   PubMed Web of Science ®Google Scholar
• Kimura T, Yokoi H, Nakagawa Y, Tamura T, Kaburagi S, Sawada Y, et al. Three-year follow-up after implantation of metallic coronary-artery stents. N Engl J Med. 1996; 334: 561–6
   PubMed Web of Science ®Google Scholar
• Laham RJ, Carrozza JP, Berger C, Cohen DJ, Kuntz RE, Baim DS. Long-term (4- to 6-year) outcome of Palmaz-Schatz stenting: Paucity of late clinical stent-related problems. J Am Coll Cardiol. 1996; 28: 820–6
   PubMed Web of Science ®Google Scholar
• Kiemeneij F, Serruys PW, Macaya C, Rutsch W, Heyndrickx G, Albertsson P, et al. Continued benefit of coronary stenting versus balloon angioplasty: Five-year clinical follow-up of Benestent-I trial. J Am Coll Cardiol. 2001; 37: 1598–603
   PubMed Web of Science ®Google Scholar
• Nakamura S, Colombo A, Gaglione A, Almagor Y, Goldberg SL, Maiello L, et al. Intracoronary ultrasound observations during stent implantation. Circulation. 1994; 89: 2026–34
   PubMed Web of Science ®Google Scholar
• Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. Randomized study with the sirolimus-coated Bx Velocity balloon-expandable stent in the treatment of patients with de nove native coronary artery lesions: A randomised comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002; 346: 1773–80
   PubMed Web of Science ®Google Scholar
• Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: A randomized controlled trial. JAMA. 2005; 294: 1215–23
   PubMed Web of Science ®Google Scholar
• Kelbaek H, Helqvist S, Thuesen L, Kløvgaard L, Jørgensen E, Saunamæki K, et al. Long-term outcome in patients treated with sirolimus-eluting stents in complex coronary artery lesions: 3-year results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress/Benestent Disease) trial. J Am Coll Cardiol. 2008; 51: 2011–6
   PubMed Web of Science ®Google Scholar
• Kelbæk H, Thuesen L, Helqvist S, Clemmensen P, Kløvgaard L, Kaltoft A, et al. Drug-eluting versus bare-metal stents in patients with ST-segment elevation myocardial infarction. Circulation. in press.
   Google Scholar
• Jørgensen E, Ripa RS, Helqvist S, Wang Y, Johnsen HE, Grande P, et al. Instent neo-intimal hyperplasia after stem cell mobilization by granulocyte-colony stimulating factor. Preliminary intracoronary ultrasound results from a double-blind randomized placebo-controlled study of patients treated with percutaneous coronary intervention for ST-Elevation Myocardial Infarction (STEMMI Trial). Int J Cardiol. 2006; 111: 174–7
   PubMed Web of Science ®Google Scholar
• Jørgensen E, Kelbæk H, Helqvist S, Jensen GV, Saunamäki K, Kastrup J, et al. Predictors of coronary in-stent restenosis. Importance of angiotensin converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors. J Am Coll Cardiol. 2001; 38: 1434–9
   PubMed Web of Science ®Google Scholar
• Jørgensen E, Kelbæk H, Helqvist S, Jensen GV, Saunamäki K, Kastrup J, et al. Low restenosis rate of the NIR coronary stent. Results of the DANSTENT study: A randomised trial comparing a first with a second generation stent. Am Heart J. 2003; 145: e5
   PubMedGoogle Scholar
• Van Weert AWM, Lesperance J, Reiber JHC. Standardization of central off-line quantitative image analysis: Implications from experiences with quantitative coronary angiography. Heart Drug. 2001; 1: 44–51
   Google Scholar
• Schatz RA, Palmaz JC, Tio FO, Garcia F, Garcia O, Reuter SR. Balloon expandable stents in the adult dog. Circulation. 1987; 76: 450–7
   PubMed Web of Science ®Google Scholar
• Robinson KA, Roubin GS, 3rd, King SB. Long-term intracoronary stent placement: Arteriographic and histologic results after 7 years in a dog model. Cathet Cardiovasc Diagn. 1996; 38: 32–7
   PubMedGoogle Scholar
• Nobuyoshi M, Kimura T, Ohishi H, Horiuchi H, Nosaka H, Hamasaki N, et al. Restenosis after percutaneous transluminal coronary angioplasty: Pathologic observations in 20 patients. J Am Coll Cardiol. 1991; 17: 433–9
   PubMed Web of Science ®Google Scholar
• Farb A, Kolodgie FD, Hwang H-D, Burke AP, Tefera K, Weber DK, et al. Extracellular matrix changes in the stented human coronary arteries. Circulation. 2004; 110: 940–7
   PubMed Web of Science ®Google Scholar
• Mauri L, Orav EJ, Kuntz RE. Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison. Circulation. 2005; 111: 3435–42
   PubMed Web of Science ®Google Scholar
• Windecker S, Remondino A, Eberli FR, Jüni P, Räber L, Wenaweser P, et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Eng J Med. 2005; 353: 653–62
   PubMed Web of Science ®Google Scholar
• Morice MC, Colombo A, Meier B, Serruys P, Tanburino C, Guagliami G, et al. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions. The REALITY Trial: A randomized controlled trial. JAMA. 2006; 295: 895–904
   PubMed Web of Science ®Google Scholar
• Bech GJ, De Bruyne B, Pijls NH, de Muinck ED, Hoorntje JC, Escaned J, et al. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: A randomized trial. Circulation. 2001; 103: 2928–34
   PubMed Web of Science ®Google Scholar